In an era of rapid digitalization and increasing attention to preventive medicine, modern dentistry is developing as one of the most dynamic fields of healthcare, requiring a new model of practice and education. The APDF White Paper — «The Power of Prevention: Evidence-Based Guidelines for Self-Oral Care» presents clinically grounded recommendations for self-oral care, emphasizes the role of daily therapeutic mouthrinses in combination with mechanical hygiene and proposes a model for translating evidence-based information into everyday practice; below is an analytical consideration of the document’s structure and key clinical findings with practical comments for the dentist.
APDF positions prevention as a central element of the strategy to reduce the burden of oral diseases, which is especially relevant given high transnational patient mobility and heterogeneity of healthcare systems; the document emphasizes the need to integrate preventive protocols at the level of primary dental care, interdisciplinary cooperation and public health to reduce barriers to the implementation of evidence-based practices. Prevention in the context of the white paper is considered not only as an individual hygiene habit but also as a component of systemic measures — patient education, digital tools for monitoring adherence, standardized protocols for at-risk groups; the numerical scale of the problem (more than 3,5 billion people with dental problems) requires a strategic approach to integrating simple and reproducible measures into clinical practice and health policy.
The authors of the white paper rely on a systematic review of clinical studies demonstrating that ordinary tooth brushing cleans about 25 percent of intraoral surfaces, whereas the gingival margin, the tongue and interproximal spaces remain areas of increased risk and require additional interventions. Inclusion of therapeutic mouthrinses showed a statistically significant reduction of plaque by 25–50 percent over six months and a reduction of gingival inflammation and bleeding by 15–30 percent in the reviewed studies; these effects have clinical significance not only for local control of biofilm but also for the potential reduction of the risk of systemic complications in patients with comorbid pathology.
The document examines in detail the pharmacological and physicochemical properties of mouthrinses — agents based on essential oils and chlorhexidine demonstrate reproducible advantages in plaque control and gingival condition; essential oils are recommended for long-term daily use, whereas chlorhexidine is recommended for short-term targeted courses in acute conditions or prior to invasive interventions. The authors confirm the safety and efficacy of these groups based on more than 50 clinical studies and indicate broad population-level adoption (over 1 billion users in more than 85 countries), while emphasizing the need to consider adverse events — staining of tissues and teeth, taste alteration with chlorhexidine, possible hypersensitivity to components of essential oils, as well as interaction with fluoride programs; the clinical recommendations include criteria for indications and contraindications, duration and regimens of use, as well as the need for documented monitoring of efficacy and tolerability in the patient.
Particular attention is paid to vulnerable patient groups: for children and adolescents the document consolidates data from 34 studies confirming a reduction in caries with daily use of fluoride-containing mouthrinses; patients with chronic somatic pathology are considered in light of the proven association between periodontal disease and cardiovascular or respiratory disorders; elderly patients and individuals with xerostomia caused by polypharmacy have an increased risk of hard tissue tooth destruction. Inclusion of a therapeutic mouthrinse in the daily routine of these groups is considered a clinically justified measure aimed at reducing postoperative complications, optimizing outcomes of periodontal therapy and decreasing the risk of systemic consequences through control of inflammatory burden.
APDF’s regional focus serves as a platform for harmonizing standards and transnational cooperation, allowing adaptation of recommendations to local epidemiological and organizational conditions; the role of educational institutions and health policy is critical to overcoming implementation barriers — this includes the creation of continuing professional development programs, integration of digital tools for remote consultation and monitoring, as well as the development of quality indicators and registries to assess the reproducibility of preventive protocols in different healthcare systems.
The APDF White Paper confirms the “prevention-first” trend in modern dentistry: the combination of mechanical hygiene, targeted use of therapeutic mouthrinses and digital translation of evidence-based information forms the basis of effective everyday practice. For clinicians, this means the need to integrate evidence-based mouthrinses into individualized prevention and treatment plans, systematic monitoring of clinical outcomes and adverse effects, participation in educational initiatives and adaptation of protocols to patient profile and regional conditions; at the same time, areas remain for further research — comparative long-term effectiveness of different formulations in real-world clinical practice, modeling of patient adherence and studying the impact of preventive interventions on systemic outcomes.
In modern implantology, based on digital technologies and interdisciplinary clinical practice, the problem of chronic inflammation around implants, caused by
For many decades, dentistry was viewed primarily as a separate field of medicine, focused on the treatment of teeth, periodontal
OTEXE.COM uses cookies to personalize the services and improve the usability of the site. If you do not want to use cookies, please disable them in your browser settings.
